Single User License
INR 11811
Site License
INR 23622
Corporate User License
INR 35432

Service Tax Additional

select a format
Price

Single User License
USD 175
Site License
USD 350
Corporate User License
USD 525

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Octapharma AG-Strategy, SWOT and Corporate Finance Report

Octapharma AG-Strategy, SWOT and Corporate Finance Report


  Request for Sample Report

Executive Summary

Octapharma AG-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Octapharma AG required for business and competitor intelligence needs

A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis

An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments

Intelligence on Octapharma AG's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Octapharma AG, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Octapharma AG and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Octapharma AG as a prospective partner, vendor or supplier

Support sales activities by understanding your customers' businesses better

Stay up to date on Octapharma AG's business structure, strategy and prospects

Key Highlights

Octapharma (or 'the group') is engaged in research and development of human proteins for various therapeutic areas. The group operates in Europe, North and South Americas, Asia Pacific and the Middle East. It is headquartered in Lachen, Switzerland, and employed 5,683 people as on December 31, 2014.

Company Snapshot

Octapharma AG: Company Overview

Octapharma AG: Overview and Key Facts

Octapharma AG: Overview

Octapharma AG: Key Facts

Octapharma AG: Key Employees

Octapharma AG: Major Products and Services

Octapharma AG: Company History

Octapharma AG: Management Statement

Octapharma AG: Locations and Subsidiaries

Octapharma AG: Key Competitors

Octapharma AG: Company Analysis

Octapharma AG: Business Description

Octapharma AG: SWOT Analysis

Octapharma AG: SWOT Overview

Octapharma AG: Strengths

Octapharma AG: Weaknesses

Octapharma AG: Opportunities

Octapharma AG: Threats

Octapharma AG: Corporate Financial Deals Activity

Octapharma AG: Financial Deals Overview

Octapharma AG: Targets and Partners

Octapharma AG: Top Deals 2012-2016YTD*

Octapharma AG: Corporate Venturing

Octapharma AG: Partnership

Octapharma AG: Recent Developments

Octapharma AG: News and Events Summary

Octapharma AG: Contracts

Octapharma AG: Financial Performance

Octapharma AG: Regulatory and Legal Events

Octapharma AG: Research & Development

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Octapharma AG: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Figure 2: Octapharma AG: Corporate Venturing Volume and Value Trend (2012-YTD*2016)

Figure 3: Octapharma AG: Corporate Venturing by Geography (2012-YTD*2016)

Figure 4: Octapharma AG: Partnership Volume and Value Trend (2012-YTD*2016)

Figure 5: Octapharma AG: Partnership Trend by Deal Type (2012-YTD*2016)

Table 1: Octapharma AG: Key Facts

Table 2: Octapharma AG: Key Employees

Table 4: Octapharma AG: Key Competitors

Table 5: Octapharma AG: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Table 6: Octapharma AG: Targets and Partners

Table 7: Octapharma AG: Top Deals 2012-2016YTD*

Table 8: Octapharma AG: Corporate Venturing Volume and Value Trend (2012-YTD*2016)

Table 9: Octapharma AG: Corporate Venturing by Geography (2012-YTD*2016)

Table 10: Octapharma AG: Partnership Volume and Value Trend (2012-YTD*2016)

Table 11: Octapharma AG: Partnership Trend by Deal Type (2012-YTD*2016)

Table 12: Octapharma AG: News and Events Summary

Table 13: Octapharma AG: Contracts

Table 14: Octapharma AG: Financial Performance

Table 15: Octapharma AG: Regulatory and Legal Events

Table 16: Octapharma AG: Research & Development

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Octapharma AG


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com